IIB is financing the international expansion of a Bulgarian pharmaceutical company
Huvepharma, a privately owned global pharmaceutical company headquartered in Bulgaria and specialising in veterinary products, has acquired a portfolio of assets from Zoetis, a major international producer of drugs, diagnostic kits and equipment for use in the veterinary field. The transaction was financed through an upsize of Huvepharma’s existing EUR 275 million facility, which was put in place in 2014. The financing was coordinated by Citi, and syndicated to a group of leading financial… Read more